Upcoming abstracts from UC Irvine Kidney faculty at ASN #KidneyWk #glomerulonephritis #mousemodels #transplant #bloodpressure Wei Ling Lau, MD Ramy Hanna FASN FACP FNKF Fawaz Al Ammary, MD, PhD, FAST

May hegglin nephropathy a case series uci original research at asn 2024 San Diego!

After spending the summer diving into nephrology with amazing mentors at UC Irvine Kidney , especially a special thanks to Ramy Hanna FASN FACP FNKF, I am glad to be here. Hope this is the first of many! American Society of Nephrology #KidneyWk

Intravitreal vegf and systemic toxicity a uci supported registry 2 year update

Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy | New England Journal of Medicine nejm.org/doi/full/10.10…

Met the one and only Dr Tangri and #epidemiology guru Eric Weinhandl #nephrology has the brightest and nicest ppl in medicine 😊 #KidneyWk American Society of Nephrology

Go say hi to my TREKS mentee med student Frank Lee at his 2 posters 406 and 864 ! #KidneyWk2024

Go say hi to my postdocs Dr Zhao and Dr Lee at 1169 and 1194 ! Especially 1194 she’s in very end of the hall… #KidneyWk2024

Impact study real world efficacy of ravilixuamb … sponsored by our partners alexion pharmaceuticals ⁦Alexion⁩

Tma complicating IgAN a case series #asn2024

Explaining impact ⁦Alexion⁩

UCI TMA TEAM… MDT TMA Data! ⁦American Society of Nephrology⁩

Matthew Nguyen ms4 presenting c5 blockade resistant cm-tma with factor B… under compassionate use authorization… courtesy of Novartis

Dr Valenti describing prolonged bedrest as a model to study hypercalciuria and #kidneystone risk in astronauts #SimulatedMicrogravity There is decrease in vasopressin, decreased protective factor osteopontin #KidneyWk2024

Check out American Society of Nephrology Podcast 🎧 on “Novel Therapies for IgA Nephropathy (IgAN)” with Matthew Sparks, MD #KidneyWk #Nephpearls 📌 Efficacy and Safety of Ravulizumab in IgAN: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial 📌 The Selective Endothelin Receptor Antagonist

Borrowed from PraveenG #nephsky 🦋 As The Lancet says “Nephrology is not for normal doctors” ❤️💙 thelancet.com/action/showPdf…

You had me at reduced complement activation Pilot study of SGLT-2 inhibitor empagliflozin shows reduced intrarenal complement activation in patients with diabetes and chronic kidney disease kireports.org/article/S2468-…